美国 · SEC FORM 4
PERRIGO Co plc
PRGO · NYSE · CIK 0001585364 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
50 同一窗口内观察到的 Form 4 交易行
0 sales · 50 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-12 · Parker Geoffrey M..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 24,240,550
- 上期报告
- 22,639,002
- 日均成交量
- 3,342,728
- 回补天数
- 7.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Parker Geoffrey M. | 买入 (P) | Ordinary Shares | 7,500 | USD 14.18 | USD 106,350 | SEC 申报 ↗ |
| 2025-09-08 | Lennox Abigail | 买入 (P) | Ordinary Shares | 1,255 | USD 22.41 | USD 28,125 | SEC 申报 ↗ |
| 2025-09-05 | Atkinson Charles | 买入 (P) | Ordinary Shares | 1,000 | USD 23.20 | USD 23,200 | SEC 申报 ↗ |
| 2025-08-22 | Willis Robert | 买入 (P) | Ordinary Shares | 1,488 | USD 24.10 | USD 35,861 | SEC 申报 ↗ |
| 2025-08-18 | Parker Geoffrey M. | 买入 (P) | Ordinary Shares | 4,375 | USD 22.97 | USD 100,494 | SEC 申报 ↗ |
| 2025-08-18 | Parker Geoffrey M. | 买入 (P) | Ordinary Shares | 4,375 | USD 22.97 | USD 100,494 | SEC 申报 ↗ |
| 2025-08-18 | Bezerra Eduardo Guarita | 买入 (P) | Ordinary Shares | 3,000 | USD 22.74 | USD 68,220 | SEC 申报 ↗ |
| 2025-08-08 | Lockwood-Taylor Patrick | 买入 (P) | Ordinary Shares | 4,460 | USD 22.37 | USD 99,774 | SEC 申报 ↗ |
| 2025-05-12 | Parker Geoffrey M. | 买入 (P) | Ordinary Shares | 3,500 | USD 27.10 | USD 94,850 | SEC 申报 ↗ |
| 2024-05-28 | Andersen Svend | 买入 (P) | Ordinary Shares | 1,000 | USD 27.90 | USD 27,900 | SEC 申报 ↗ |
| 2024-03-05 | Ives Alison | 买入 (P) | Ordinary Shares | 2,490 | USD 27.26 | USD 67,877 | SEC 申报 ↗ |
| 2024-03-01 | Willis Robert | 买入 (P) | Ordinary Shares | 371 | USD 26.30 | USD 9,757 | SEC 申报 ↗ |
| 2024-02-29 | Ives Alison | 买入 (P) | Ordinary Shares | 1,545 | USD 26.44 | USD 40,850 | SEC 申报 ↗ |
| 2024-02-29 | Willis Robert | 买入 (P) | Ordinary Shares | 6,000 | USD 25.87 | USD 155,220 | SEC 申报 ↗ |
| 2024-02-29 | Lockwood-Taylor Patrick | 买入 (P) | Ordinary Shares | 9,500 | USD 26.54 | USD 252,130 | SEC 申报 ↗ |
Form 4 申报证据
77 transaction lines in the latest 365-day window; 623 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Parker Geoffrey M. | 期权行权／转换 (M) | Ordinary Shares | 1,263 | USD 13.66 | USD 17,253 | SEC 申报 ↗ |
| 2026-09-11 | Parker Geoffrey M. | 代扣税 (F) | Ordinary Shares | 607 | USD 13.66 | USD 8,292 | SEC 申报 ↗ |
| 2026-09-11 | Alford Bradley A | 期权行权／转换 (M) | Ordinary Shares | 1,263 | USD 13.66 | USD 17,253 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Parker Geoffrey M. | 期权行权／转换 (M) | Ordinary Shares | 1,263 | USD 13.66 | USD 17,253 | SEC 申报 ↗ |
| 2026-09-11 | Parker Geoffrey M. | 代扣税 (F) | Ordinary Shares | 607 | USD 13.66 | USD 8,292 | SEC 申报 ↗ |
| 2026-09-11 | Alford Bradley A | 期权行权／转换 (M) | Ordinary Shares | 1,263 | USD 13.66 | USD 17,253 | SEC 申报 ↗ |
| 2026-09-11 | Alford Bradley A | 代扣税 (F) | Ordinary Shares | 607 | USD 13.66 | USD 8,292 | SEC 申报 ↗ |
| 2026-09-09 | Ball David | 期权行权／转换 (M) | Ordinary Shares | 7,701 | USD 14.34 | USD 110,432 | SEC 申报 ↗ |
| 2026-09-09 | Ball David | 代扣税 (F) | Ordinary Shares | 2,784 | USD 14.34 | USD 39,923 | SEC 申报 ↗ |
| 2026-07-08 | Winterman Matthew John | 期权行权／转换 (M) | Ordinary Shares | 17,503 | USD 10.52 | USD 184,132 | SEC 申报 ↗ |
| 2026-07-08 | Winterman Matthew John | 代扣税 (F) | Ordinary Shares | 9,138 | USD 10.52 | USD 96,132 | SEC 申报 ↗ |
| 2026-07-08 | Khoury Roberto | 期权行权／转换 (M) | Ordinary Shares | 737 | USD 10.52 | USD 7,753 | SEC 申报 ↗ |
| 2026-07-08 | Khoury Roberto | 代扣税 (F) | Ordinary Shares | 385 | USD 10.52 | USD 4,050 | SEC 申报 ↗ |
| 2026-06-12 | Parker Geoffrey M. | 期权行权／转换 (M) | Ordinary Shares | 976 | USD 10.99 | USD 10,726 | SEC 申报 ↗ |
| 2026-06-12 | Parker Geoffrey M. | 代扣税 (F) | Ordinary Shares | 469 | USD 10.99 | USD 5,154 | SEC 申报 ↗ |
| 2026-06-12 | Alford Bradley A | 期权行权／转换 (M) | Ordinary Shares | 976 | USD 10.99 | USD 10,726 | SEC 申报 ↗ |
| 2026-06-12 | Alford Bradley A | 代扣税 (F) | Ordinary Shares | 469 | USD 10.99 | USD 5,154 | SEC 申报 ↗ |
| 2026-06-05 | Lockwood-Taylor Patrick | 期权行权／转换 (M) | Ordinary Shares | 25,230 | USD 10.83 | USD 273,241 | SEC 申报 ↗ |
| 2026-06-05 | Lockwood-Taylor Patrick | 代扣税 (F) | Ordinary Shares | 12,906 | USD 10.83 | USD 139,772 | SEC 申报 ↗ |
| 2026-06-05 | Willis Robert | 期权行权／转换 (M) | Ordinary Shares | 3,441 | USD 10.83 | USD 37,266 | SEC 申报 ↗ |
| 2026-06-05 | Willis Robert | 代扣税 (F) | Ordinary Shares | 1,797 | USD 10.83 | USD 19,462 | SEC 申报 ↗ |
| 2026-06-05 | Lennox Abigail | 期权行权／转换 (M) | Ordinary Shares | 3,823 | USD 10.83 | USD 41,403 | SEC 申报 ↗ |
| 2026-06-05 | Lennox Abigail | 代扣税 (F) | Ordinary Shares | 1,996 | USD 10.83 | USD 21,617 | SEC 申报 ↗ |
| 2026-06-05 | Khoury Roberto | 期权行权／转换 (M) | Ordinary Shares | 17,902 | USD 10.83 | USD 193,879 | SEC 申报 ↗ |
| 2026-06-05 | Khoury Roberto | 代扣税 (F) | Ordinary Shares | 9,346 | USD 10.83 | USD 101,217 | SEC 申报 ↗ |
| 2026-06-05 | Bezerra Eduardo Guarita | 期权行权／转换 (M) | Ordinary Shares | 9,175 | USD 10.83 | USD 99,365 | SEC 申报 ↗ |
| 2026-06-05 | Bezerra Eduardo Guarita | 代扣税 (F) | Ordinary Shares | 2,235 | USD 10.83 | USD 24,205 | SEC 申报 ↗ |
| 2026-06-05 | Ball David | 期权行权／转换 (M) | Ordinary Shares | 2,867 | USD 10.83 | USD 31,050 | SEC 申报 ↗ |
| 2026-06-05 | Ball David | 代扣税 (F) | Ordinary Shares | 1,037 | USD 10.83 | USD 11,231 | SEC 申报 ↗ |
| 2026-06-05 | Atkinson Charles | 期权行权／转换 (M) | Ordinary Shares | 6,690 | USD 10.83 | USD 72,453 | SEC 申报 ↗ |
| 2026-06-05 | Atkinson Charles | 代扣税 (F) | Ordinary Shares | 1,835 | USD 10.83 | USD 19,873 | SEC 申报 ↗ |
| 2026-05-15 | Alford Bradley A | 代扣税 (F) | Ordinary Shares | 3,507 | USD 10.84 | USD 38,016 | SEC 申报 ↗ |
| 2026-05-14 | Samuelson Jonas | 期权行权／转换 (M) | Ordinary Shares | 7,305 | USD 10.84 | USD 79,186 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | PRGO |
| CIK | 0001585364 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 623 transaction lines from 2020-02-07 to 2026-09-11 38 P purchase lines · 23 S sale lines · 562 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.